Harmony Biosciences Holdings (HRMY) Current Assets (2019 - 2026)

Harmony Biosciences Holdings has disclosed Current Assets across 8 years of filings, most recently posting $778.8 million for Q1 2026.

• Current Assets for Q1 2026 came in at $778.8 million, up 21.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $778.8 million (up 21.18% YoY), and the FY2025 annual result was $907.0 million, up 56.58% from the prior year.
• Current Assets came in at $778.8 million for Q1 2026 at Harmony Biosciences Holdings, down from $907.0 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $907.0 million in Q4 2025 to a low of $280.3 million in Q1 2022.
• The 5-year median for Current Assets is $463.0 million (2023), against an average of $533.6 million.
• Across the five-year window, Current Assets rose 0.59% in 2024 and jumped 60.57% in 2025, its largest moves.
• Harmony Biosciences Holdings' Current Assets stood at $400.3 million in 2022, then rose by 12.69% to $451.1 million in 2023, then gained by 28.42% to $579.3 million in 2024, then surged by 56.58% to $907.0 million in 2025, then slipped by 14.13% to $778.8 million in 2026.
• The last three Current Assets figures came in at $778.8 million (Q1 2026), $907.0 million (Q4 2025), and $838.8 million (Q3 2025), per Business Quant data.